GB2463452A — Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
Assigned to Valeant Laboratories International Bermuda SRL · Expires 2010-03-17 · 16y expired
What this patent protects
Pharmaceutical compositions comprising a compound of the formula (1):or a pharmaceutically acceptable salt or tautomer thereof and a pharmaceutically acceptable carrier and compounds of formula (1) per se or pharmaceutically acceptable salts or tautomers thereof, excluding certai…
USPTO Abstract
Pharmaceutical compositions comprising a compound of the formula (1):or a pharmaceutically acceptable salt or tautomer thereof and a pharmaceutically acceptable carrier and compounds of formula (1) per se or pharmaceutically acceptable salts or tautomers thereof, excluding certain isomers. R1and R2are each hydrogen or methyl, provided at least one of R1and R2is hydrogen, and X is CHOH or C=O. The compounds are 1,3,4,6,7,11b-hexahydrobenzo(a)quinolizine compounds, more specifically desmethyl derivatives of tetrabenazine, and may be useful in treating various diseases, in particular movement disorders such as Huntington's disease or Tourette's syndrome, depression, inflammatory disease, asthma, multiple sclerosis or an autoimmune myelitis, psychoses, cognitive deficit, schizophrenia, anxiety, dementia or diabetes mellitus.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.